Moloney Securities Asset Management LLC Boosts Position in Roche Holding AG (OTCMKTS:RHHBY)

Moloney Securities Asset Management LLC lifted its stake in Roche Holding AG (OTCMKTS:RHHBY - Free Report) by 53.8% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 40,732 shares of the company's stock after purchasing an additional 14,245 shares during the quarter. Moloney Securities Asset Management LLC's holdings in Roche were worth $1,672,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently made changes to their positions in RHHBY. HighPoint Advisor Group LLC raised its stake in shares of Roche by 2.8% in the fourth quarter. HighPoint Advisor Group LLC now owns 11,091 shares of the company's stock worth $387,000 after purchasing an additional 304 shares during the last quarter. Fulton Bank N.A. increased its holdings in Roche by 2.6% in the 1st quarter. Fulton Bank N.A. now owns 12,620 shares of the company's stock worth $518,000 after buying an additional 314 shares in the last quarter. GAMMA Investing LLC raised its position in Roche by 59.5% in the 1st quarter. GAMMA Investing LLC now owns 12,850 shares of the company's stock worth $529,000 after buying an additional 4,794 shares during the last quarter. Confluence Investment Management LLC raised its position in Roche by 3.6% in the 1st quarter. Confluence Investment Management LLC now owns 14,491 shares of the company's stock worth $596,000 after buying an additional 510 shares during the last quarter. Finally, Minot DeBlois Advisors LLC purchased a new position in Roche in the 4th quarter worth about $752,000.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the company. Hsbc Global Res cut Roche from a "strong-buy" rating to a "hold" rating in a report on Monday, April 28th. HSBC cut Roche from a "buy" rating to a "hold" rating in a report on Monday, April 28th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, one has given a buy rating and two have given a strong buy rating to the company. According to MarketBeat, Roche presently has a consensus rating of "Moderate Buy".

Roche Trading Up 1.9%

Shares of OTCMKTS:RHHBY traded up $0.78 during trading on Wednesday, reaching $40.87. The stock had a trading volume of 1,010,783 shares, compared to its average volume of 2,513,252. The company has a quick ratio of 1.20, a current ratio of 1.48 and a debt-to-equity ratio of 0.85. The firm's 50-day simple moving average is $40.09 and its 200 day simple moving average is $39.61. Roche Holding AG has a one year low of $34.10 and a one year high of $44.31.

Roche Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.